Literature DB >> 29708161

Best practice for sepsis.

Jordi Rello1, Francesca Rubulotta2.   

Abstract

Entities:  

Year:  2018        PMID： 29708161      PMCID： PMC5906331          DOI： 10.21037/jtd.2018.03.29

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?

Authors:  Jordi Rello; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

2.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuck Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 3.  Precision medicine for the treatment of severe pneumonia in intensive care.

Authors:  Jordi Rello; Antonio Perez
Journal:  Expert Rev Respir Med       Date:  2016-02-09       Impact factor: 3.772

4.  Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.

Authors:  Nikolay P Braykov; Daniel J Morgan; Marin L Schweizer; Daniel Z Uslan; Theodoros Kelesidis; Scott A Weisenberg; Birgir Johannsson; Heather Young; Joseph Cantey; Arjun Srinivasan; Eli Perencevich; Edward Septimus; Ramanan Laxminarayan
Journal:  Lancet Infect Dis       Date:  2014-11-17       Impact factor: 25.071

5.  Impact of an electronic sepsis initiative on antibiotic use and health care facility-onset Clostridium difficile infection rates.

Authors:  Robert Hiensch; Jashvant Poeran; Patricia Saunders-Hao; Victoria Adams; Charles A Powell; Allison Glasser; Madhu Mazumdar; Gopi Patel
Journal:  Am J Infect Control       Date:  2017-06-08       Impact factor: 2.918

6.  Time to initial antibiotic administration, and short-term mortality among patients admitted with community-acquired severe infections with and without the presence of systemic inflammatory response syndrome: a follow-up study.

Authors:  Daniel Pilsgaard Henriksen; Christian B Laursen; Jesper Hallas; Court Pedersen; Annmarie Touborg Lassen
Journal:  Emerg Med J       Date:  2015-03-11       Impact factor: 2.740

7.  Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial.

Authors:  Nadia Alam; Erick Oskam; Patricia M Stassen; Pieternel van Exter; Peter M van de Ven; Harm R Haak; Frits Holleman; Arthur van Zanten; Hien van Leeuwen-Nguyen; Victor Bon; Bart A M Duineveld; Rishi S Nannan Panday; Mark H H Kramer; Prabath W B Nanayakkara
Journal:  Lancet Respir Med       Date:  2017-11-28       Impact factor: 30.700
  7 in total
  2 in total

1.  Author's response to commentary on the PHANTASi trial.

Authors:  Rishi S Nannan Panday; Eline M J Lammers; Nadia Alam; Prabath W B Nanayakkara
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Lactate-enhanced-qSOFA (LqSOFA) score is superior to the other four rapid scoring tools in predicting in-hospital mortality rate of the sepsis patients.

Authors:  Sijia Liu; Chengqi He; Weilue He; Tian Jiang
Journal:  Ann Transl Med       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.